Biliary tract cancers are low-radiosensitive adenocarcinomas and occur in deep-seated organs. Furthermore, normal tissues with higher radiosensitivity exist contiguously with the diseased sites. For these reasons, radiation therapy has not been considered as a good indication for these cancers.
Since the prolonged survival achieved by 30- to 60-Gy external beam radiation therapy was reported in the 1970s, in addition to intraoperative radiation therapy, postoperative radiation therapy, and intraluminal brachytherapy, combinations of external radiation therapy and chemotherapy have come into use.
The purpose of radiation therapy for unresectable biliary tract cancer is to prolonged survival or prolonged stent patency, and to provide palliation of pain. For unresectable bile duct cancer, there are a number of studies showing that radiation therapy is superior to the best supportive care.
As radiation therapy, external-beam radiation therapy is usually performed, but combined use of intraluminal brachytherapy with external beam radiotherapy is more useful for making the treatment more effective.
A number of studies show the usefulness of radiation therapy for biliary tract cancer, but most of these studies are small prospective or retrospective studies. Thus, radiation therapy is not a standard treatment in biliary tract cancer. Implementation of large multi-institional RCTs is desired.
View full abstract